Cargando…

Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol

Elevated basal insulin secretion under fasting conditions together with insufficient stimulated insulin release is an important hallmark of type 2 diabetes, but the mechanisms controlling basal insulin secretion remain unclear. Membrane rafts exist in pancreatic islet cells and spatially organize me...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaraj, Vini, Kazim, Abdulla S., Helgeson, Johan, Lewold, Clemens, Barik, Satadal, Buda, Pawel, Reinbothe, Thomas M., Wennmalm, Stefan, Zhang, Enming, Renström, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045496/
https://www.ncbi.nlm.nih.gov/pubmed/27533789
http://dx.doi.org/10.1210/me.2016-1023
_version_ 1782457129489137664
author Nagaraj, Vini
Kazim, Abdulla S.
Helgeson, Johan
Lewold, Clemens
Barik, Satadal
Buda, Pawel
Reinbothe, Thomas M.
Wennmalm, Stefan
Zhang, Enming
Renström, Erik
author_facet Nagaraj, Vini
Kazim, Abdulla S.
Helgeson, Johan
Lewold, Clemens
Barik, Satadal
Buda, Pawel
Reinbothe, Thomas M.
Wennmalm, Stefan
Zhang, Enming
Renström, Erik
author_sort Nagaraj, Vini
collection PubMed
description Elevated basal insulin secretion under fasting conditions together with insufficient stimulated insulin release is an important hallmark of type 2 diabetes, but the mechanisms controlling basal insulin secretion remain unclear. Membrane rafts exist in pancreatic islet cells and spatially organize membrane ion channels and proteins controlling exocytosis, which may contribute to the regulation of insulin secretion. Membrane rafts (cholesterol and sphingolipid containing microdomains) were dramatically reduced in human type 2 diabetic and diabetic Goto-Kakizaki (GK) rat islets when compared with healthy islets. Oxidation of membrane cholesterol markedly reduced microdomain staining intensity in healthy human islets, but was without effect in type 2 diabetic islets. Intriguingly, oxidation of cholesterol affected glucose-stimulated insulin secretion only modestly, whereas basal insulin release was elevated. This was accompanied by increased intracellular Ca(2+) spike frequency and Ca(2+) influx and explained by enhanced single Ca(2+) channel activity. These results suggest that the reduced presence of membrane rafts could contribute to the elevated basal insulin secretion seen in type 2 diabetes.
format Online
Article
Text
id pubmed-5045496
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-50454962016-10-18 Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol Nagaraj, Vini Kazim, Abdulla S. Helgeson, Johan Lewold, Clemens Barik, Satadal Buda, Pawel Reinbothe, Thomas M. Wennmalm, Stefan Zhang, Enming Renström, Erik Mol Endocrinol Original Research Elevated basal insulin secretion under fasting conditions together with insufficient stimulated insulin release is an important hallmark of type 2 diabetes, but the mechanisms controlling basal insulin secretion remain unclear. Membrane rafts exist in pancreatic islet cells and spatially organize membrane ion channels and proteins controlling exocytosis, which may contribute to the regulation of insulin secretion. Membrane rafts (cholesterol and sphingolipid containing microdomains) were dramatically reduced in human type 2 diabetic and diabetic Goto-Kakizaki (GK) rat islets when compared with healthy islets. Oxidation of membrane cholesterol markedly reduced microdomain staining intensity in healthy human islets, but was without effect in type 2 diabetic islets. Intriguingly, oxidation of cholesterol affected glucose-stimulated insulin secretion only modestly, whereas basal insulin release was elevated. This was accompanied by increased intracellular Ca(2+) spike frequency and Ca(2+) influx and explained by enhanced single Ca(2+) channel activity. These results suggest that the reduced presence of membrane rafts could contribute to the elevated basal insulin secretion seen in type 2 diabetes. Endocrine Society 2016-10 2016-08-17 /pmc/articles/PMC5045496/ /pubmed/27533789 http://dx.doi.org/10.1210/me.2016-1023 Text en http://creativecommons.org/licenses/by-nc/4.0/ This article is published under the terms of the Creative Commons Attribution-Non Commercial License (CC-BY-NC; http://creativecommons.org/licenses/by-nc/4.0/).
spellingShingle Original Research
Nagaraj, Vini
Kazim, Abdulla S.
Helgeson, Johan
Lewold, Clemens
Barik, Satadal
Buda, Pawel
Reinbothe, Thomas M.
Wennmalm, Stefan
Zhang, Enming
Renström, Erik
Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol
title Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol
title_full Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol
title_fullStr Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol
title_full_unstemmed Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol
title_short Elevated Basal Insulin Secretion in Type 2 Diabetes Caused by Reduced Plasma Membrane Cholesterol
title_sort elevated basal insulin secretion in type 2 diabetes caused by reduced plasma membrane cholesterol
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045496/
https://www.ncbi.nlm.nih.gov/pubmed/27533789
http://dx.doi.org/10.1210/me.2016-1023
work_keys_str_mv AT nagarajvini elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT kazimabdullas elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT helgesonjohan elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT lewoldclemens elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT bariksatadal elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT budapawel elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT reinbothethomasm elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT wennmalmstefan elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT zhangenming elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol
AT renstromerik elevatedbasalinsulinsecretionintype2diabetescausedbyreducedplasmamembranecholesterol